The validity of breath collection bags method in detecting Helicobacter pylori using the novel BreathID ® Hp Lab System : a multicenter clinical study in 257 subjects.

Background and Aim: The BreathID ® Hp urea breath test provides several advantages over other 13C breath analyzers for the detection of Helicobacter pylori. We evaluated the sensitivity and specificity of a new BreathID ® Hp Lab System (Exalenz Bioscience Ltd, Israel), a 13C-urea breath test system...

Descripción completa

Detalles Bibliográficos
Publicado en:Therapeutic Advances in Gastrointestinal Endoscopy Vol. 12
Autores principales: Richter, Vered, Gonzalez, Jeff O., Hazan, Sabine, Gottlieb, Gary, Friedenberg, Keith, Gatof, David, Ganeshappa, Ravi, Delgado, Jorge-Shmuel, Abramowitz, Dov, Hardi, Robert, Coates, Allan, Haq, Mahmudul, Mehta, Nilesh, Jones, Blake A., Moss, Steven F., Shirin, Haim
Formato: clinical trial pictorial research tables/charts Journal Article
Publicado: Sage Publications Inc. 5/30/2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138595247&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 138595247
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        26317745
        M8AA
      jtl: Therapeutic Advances in Gastrointestinal Endoscopy
      issn: 26317745
      maglogo: Y
    pubinfo:
      dt: 5/30/2019
      vid: 12
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        138595247
        138595247
        138595247
        10.1177/2631774519843401
        138595247
      ppct: 1
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: The validity of breath collection bags method in detecting Helicobacter pylori using the novel BreathID ® Hp Lab System : a multicenter clinical study in 257 subjects.
      aug:
        au:
          Richter, Vered
          Gonzalez, Jeff O.
          Hazan, Sabine
          Gottlieb, Gary
          Friedenberg, Keith
          Gatof, David
          Ganeshappa, Ravi
          Delgado, Jorge-Shmuel
          Abramowitz, Dov
          Hardi, Robert
          Coates, Allan
          Haq, Mahmudul
          Mehta, Nilesh
          Jones, Blake A.
          Moss, Steven F.
          Shirin, Haim
        affil: Institute of Gastroenterology, Liver Diseases and Nutrition, Assaf Harofeh Medical Center, Tel-Aviv University, Zerifin, Israel
      sug:
        subj:
          Sensitivity and Specificity
          Helicobacter Infections Diagnosis
          Breath Tests Methods
          Urea Diagnostic Use
          Breath Tests Equipment and Supplies
          Isotopes Diagnostic Use
          Human
          Multicenter Studies
          Histology
          Urea Metabolism
          Helicobacter Pylori Metabolism
          Helicobacter Infections Microbiology
          Urease Metabolism
          Pretest-Posttest Design
          Reproducibility of Results
          Stability
          Descriptive Statistics
          Immunohistochemistry
          Biopsy
          Helicobacter Infections Pathology
          Urease Diagnostic Use
          Patient Safety
          United States
          Israel
          Male
          Female
          Adult
          Middle Age
          Aged
          Endoscopy, Gastrointestinal
          Confidence Intervals
          kappa Statistic
          Comparative Studies
          Clinical Trials
          Funding Source
          Technology, Medical
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Background and Aim: The BreathID ® Hp urea breath test provides several advantages over other 13C breath analyzers for the detection of Helicobacter pylori. We evaluated the sensitivity and specificity of a new BreathID ® Hp Lab System (Exalenz Bioscience Ltd, Israel), a 13C-urea breath test system using breath sampling bags that facilitates multiple testing in a multicenter international clinical study. Methods: A total of 257 subjects with evaluable results for urea breath test, rapid urease test, and histology were enrolled into two study groups: 189 naïve subjects were included in the pre-therapy group, and 68 subjects comprised the post-eradication therapy group. Analytical studies were conducted to evaluate the stability, reproducibility, and repeatability of the 13C-urea breath test results using a delta over baseline cut-off value of 5. Results: Among the pre-therapy subjects evaluated with the composite results from the rapid urease test and histology/immunohistochemistry, 176 results matched those of the urea breath test, resulting in an overall agreement of 98.3% with a sensitivity of 100% and specificity of 97.9%. In the post-eradication therapy cohort, the overall agreement between the urea breath test and the biopsy diagnosis was 98.5%; the sensitivity of the urea breath test in this cohort was 92.3% and the specificity was 100%. There was uniformly high overall reproducibility (99.48%) of the test results over different batches of breath sample bags, when analyzed on different days and under different storage conditions, showing stability of the breath samples in the breath collection bags Conclusion: The BreathID ® Hp Lab System is a highly accurate and dependable method for the diagnosis of H. pylori infection.
      pubtype: Academic Journal
      doctype:
        clinical trial
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N